Ozgur Tunceli

723 total citations
36 papers, 552 citations indexed

About

Ozgur Tunceli is a scholar working on Pulmonary and Respiratory Medicine, Economics and Econometrics and Epidemiology. According to data from OpenAlex, Ozgur Tunceli has authored 36 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 11 papers in Economics and Econometrics and 7 papers in Epidemiology. Recurrent topics in Ozgur Tunceli's work include Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers), Asthma and respiratory diseases (7 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Ozgur Tunceli is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers), Asthma and respiratory diseases (7 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Ozgur Tunceli collaborates with scholars based in United States, United Kingdom and Singapore. Ozgur Tunceli's co-authors include David M. Kern, Bingcao Wu, Vincent J. Willey, Iftekhar Kalsekar, Suma Vupputuri, Amy H. Stanford, Kelly Bell, Frank Trudo, Jill Davis and Setareh A. Williams and has published in prestigious journals such as Journal of Clinical Oncology, Vaccine and BMC Health Services Research.

In The Last Decade

Ozgur Tunceli

36 papers receiving 530 citations

Peers

Countries citing papers authored by Ozgur Tunceli

Since Specialization

Citations

This map shows the geographic impact of Ozgur Tunceli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ozgur Tunceli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ozgur Tunceli more than expected).

Fields of papers citing papers by Ozgur Tunceli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ozgur Tunceli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ozgur Tunceli. The network helps show where Ozgur Tunceli may publish in the future.

Co-authorship network of co-authors of Ozgur Tunceli

This figure shows the co-authorship network connecting the top 25 collaborators of Ozgur Tunceli. A scholar is included among the top collaborators of Ozgur Tunceli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ozgur Tunceli. Ozgur Tunceli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Healthcare Integrated Research Database (HIRD) as a Real‐World Data Source for Pharmacoepidemiologic Research 2025 ·Pharmacoepidemiology and Drug Safety ·John J. Barron, Vincent J. Willey, (unknown), Ozgur Tunceli, (unknown), Michael Grabner, Daniel C. Beachler, Stephan Lanes, Mark J. Cziraky	2
2	PDB38 REAL-WORLD COMPARISON OF HOSPITALIZATION COSTS FOR HEART FAILURE IN T2DM PATIENTS WITH CARDIOVASCULAR DISEASE TREATED WITH CANAGLIFLOZIN VERSUS OTHER ANTIHYPERGLYCEMIC AGENTS 2019 ·Value in Health ·(unknown), (unknown), Ozgur Tunceli, Christopher D. Pericone, Brahim Bookhart, Michael Durkin	1
3	Factors Associated with the Initiation of Long-Acting Injectable Paliperidone Palmitate Versus Aripiprazole Among Medicaid Patients with Schizophrenia: An Observational Study 2019 ·Advances in Therapy ·Qian Cai, Charmi Patel, Edward Kim, (unknown), Ozgur Tunceli, Antoine C. El Khoury	2
4	Estimating the Real-World Cost of Diabetes Mellitus in the United States During an 8-Year Period Using 2 Cost Methodologies. 2018 ·PubMed ·Vincent J. Willey, Sheldon X. Kong, Bingcao Wu, Amit D. Raval, Todd Hobbs, (unknown), Gaurav Deshpande, Ozgur Tunceli, Brian Sakurada, Jonathan Bouchard	17
5	Cost of Care for Patients with Metastatic Castration-Resistant Prostate Cancer in US Commercially Insured and Medicare Supplement Plans 2018 ·Value in Health ·Bingcao Wu, (unknown), Ozgur Tunceli, Christopher D. Pericone, Zhijie Ding, (unknown), (unknown), Nancy A. Dawson	2
6	Treatment patterns, healthcare utilization, and costs of chronic opioid treatment for non-cancer pain in the United States. 2015 ·PubMed ·David M. Kern, (unknown), (unknown), Ozgur Tunceli, Mark Sostek, Joseph Singer, Robert LoCasale	37
7	Statistical Assessment of a Case-Finding Algorithm for Identifying Non-Small Cell Lung Cancer (Nsclc) Patients in Administrative Claims Databases 2015 ·Value in Health ·(unknown), (unknown), (unknown), Ozgur Tunceli, (unknown), (unknown)	1
8	Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study 2015 ·Respiratory Research ·David M. Kern, Jill Davis, Setareh A. Williams, Ozgur Tunceli, Bingcao Wu, Sally Hollis, Charlie Strange, Frank Trudo	26
9	Mortality, Outcomes, and Healthcare Costs in T2DM Patients at Risk for Cardiovascular Disease 2015 ·The American Journal of Managed Care ·David M. Kern, (unknown), (unknown), Ozgur Tunceli, Bingcao Wu, (unknown)	3
10	Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments 2015 ·International Journal of COPD ·David M. Kern, Frank Trudo, Setareh A. Williams, Jill Davis, Ozgur Tunceli, (unknown), (unknown), Charlie Strange	15
11	Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: Doubled Costs Compared with Patients with Asthma Alone 2015 ·Value in Health ·Maria Gerhardsson de Verdier, (unknown), David M. Kern, (unknown), Ozgur Tunceli	31
12	Assessment of Outpatient and Inpatient Antibiotic Treatment Patterns and Health Care Costs of Patients with Complicated Urinary Tract Infections 2015 ·Clinical Therapeutics ·Ralph M. Turner, Bingcao Wu, Kenneth Lawrence, Judith Hackett, Sudeep Karve, Ozgur Tunceli	21
13	Healthcare utilization and costs associated with S. aureus and P. aeruginosa pneumonia in the intensive care unit: a retrospective observational cohort study in a US claims database 2015 ·BMC Health Services Research ·Moe H. Kyaw, David M. Kern, (unknown), Ozgur Tunceli, Hasan S. Jafri, Judith Falloon	30
14	Cost Profile of Patients with Gastric Cancer Using United States Administrative Claims Data 2014 ·Value in Health ·Ceri Hirst, James Ryan, Ozgur Tunceli, Bingcao Wu, David M. Kern	1
15	Seasonal influenza vaccination trends from 2007–2011 in privately insured children and adults in the United States 2014 ·Vaccine ·Evgeniya Antonova, Christopher S. Ambrose, David M. Kern, Stan L. Block, Hervé Caspard, Ozgur Tunceli	7
16	Comparative Effectiveness of Budesonide-Formoterol Combination and Fluticasone-Salmeterol Combination for Asthma Management: A United States Retrospective Database Analysis 2014 ·The Journal of Allergy and Clinical Immunology In Practice ·Ozgur Tunceli, Setareh A. Williams, David M. Kern, Hanaa Elhefni, (unknown), Catrin Wessman, (unknown), Frank Trudo	13
17	Establishing a weighting methodology to compute the number of patients with disease using claims data and census population in the united states 2013 ·Value in Health ·Thomas Wasser, Bingcao Wu, J. Ycas, Ozgur Tunceli, Mark J. Cziraky	1
18	Comparison of commercial insurance databases to census data for age, gender and geographic region in the united states 2013 ·Value in Health ·Thomas Wasser, Bingcao Wu, J. Ycas, Ozgur Tunceli, Mark J. Cziraky	4
19	Treatment Patterns, HealthCare Resource Utilization and Costs in Patients with Bipolar Disorder, Newly Treated with Extended Release or Immediate Release Quetiapine Fumarate using US Healthcare Administrative Claims Data 2013 ·Clinical Therapeutics ·Julie Locklear, Berhanu Alemayehu, Robert S. Brody, (unknown), Ozgur Tunceli, David M. Kern, Willie Earley	6
20	Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods 2010 ·Current Medical Research and Opinion ·Ozgur Tunceli, (unknown), Tao Gu, Jonathan Bouchard, Mark Aagren, Wei Luo	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact